Sandi McQuaide has been a loyal customer of Martella’s Pharmacy in Johnstown for 45 years and said she is devastated that an intermediary in the pharmaceutical industry is days from taking away her ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...

Q2 2025 Earnings Call Transcript August 13, 2025 ARS Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $ ...

Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...

Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.

Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and PBMI Innovator Award winner, is calling for a PBM industry focus on making pharmacy experiences more seamless while continuing to ...

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...

O'Reilly Automotive Inc. is suing the three major pharmacy benefit managers in the U.S., as well as the three major insulin manufacturers.

The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its ...

CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found it violated state code. The $1.4 million fine is based on 2,871 violations, ...

In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and ...

Now, it’s worth noting Stock Advisor’s total average return is 1,036% — a market-crushing outperformance compared to 181 % ...